aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with the mission to revolutionize drug discovery and development, Terremoto Biosciences focuses on leveraging lysine-based covalent chemistry to create optimized small molecule medicines. The company aims to deliver superior therapeutic benefits through innovative biotechnology solutions, targeting a broad market within the pharmaceutical and healthcare sectors.
Terremoto Biosciences has attracted notable investors and industry experts, contributing to its rapid growth and development. Key achievements include significant advancements in covalent chemistry applications, positioning the company as a leader in next-generation medicine development. The overall impact of Terremoto Biosciences is marked by its potential to transform therapeutic outcomes and improve patient care on a global scale.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Medicine Development
Technology
Biotech
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Terremoto Biosciences founded?
Terremoto Biosciences was founded in 2021.
Where is Terremoto Biosciences's headquarters located?
Terremoto Biosciences's headquarters is located in San Francisco, CA, US.
When was Terremoto Biosciences's last funding round?
Terremoto Biosciences's most recent funding round was for $175M (USD) in November 2023.
How many employees does Terremoto Biosciences have?
Terremoto Biosciences has 41 employees as of Feb 5, 2024.
How much has Terremoto Biosciences raised to-date?
As of July 05, 2023, Terremoto Biosciences has raised a total of $250M (USD) since Nov 2, 2023.
Add Comparison
Total Raised to Date
$250M
USD
Last Update Nov 2, 2023
Last Deal Details
$175M
USD
Nov 2, 2023
Series B
Total Employees Over Time
41
As of Feb 2024
Terremoto Biosciences Address
1700 Owens Street
Suite 540
San Francisco,
California
94158
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts